Salmonella Typhi Vi polysaccharide conjugate vaccine protects infants and children against typhoid fever
نویسندگان
چکیده
The past decade has seen remarkable progress in our understanding of the scale global typhoid fever problem,1 alarming emergence south Asia extensively drug-resistant Salmonella enterica serovar Typhi (S Typhi) threatening effective treatment,2 and WHO prequalification a conjugate vaccine,3 new tool to prevent disease. In Lancet, Firdausi Qadri colleagues report analysis 18 months follow-up cluster-randomised trial prequalified S Vi polysaccharide tetanus toxoid vaccine (Vi-TT; Tybar TCV, Bharat Biotech International, Hyderabad, India) among infants children aged 9 younger than 16 years densely populated highly mobile urban area Mirpur, Dhaka, Bangladesh.
منابع مشابه
A conjugate vaccine against typhoid fever.
90 www.thelancet.com/infection Vol 14 February 2014 Zulfi qar Bhutta and colleages’ study in The Lancet Infectious Diseases marks an important milestone for the use of typhoid conjugate vaccines. Present Vi polysaccharide vaccines (Vi-PS) are not widely used because they cannot be given to children younger than 2 years and are thus excluded from the Expanded Programme of Immunization (EPI); fur...
متن کاملSafety and Immunogenicity of Salmonella Typhi Vi conjugate vaccine (Peda TyphTM) in children upto five years
Background: Conjugate typhoid vaccine can prevent increasing cases of typhoid in younger children. Commercially available conjugate vaccine has limited studies to support its use. Aims: To study the safety and immunogenicity of Vi conjugate typhoid vaccine (PedaTyph TM ). Materials and Methods: Four hundred children with age <5 years were randomised to receive either one dose (Group A) or two d...
متن کاملEfficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
OBJECTIVE To test the efficacy of locally produced Vi vaccine over a time period of longer than one year. METHODS A double-blinded, randomized field trial was performed in Guangxi Zhuang Autonomous Region in south-western China, using 30 micrograms doses of locally produced Vi. Enrolled subjects were 3-50 years of age, although the majority (92%) were school-aged children, who have the highes...
متن کاملEfficacy of purified Vi polysaccharide typhoid vaccine.
This experiment was conducted to assess the efficacy of typhoid vaccine newly produced by purifying Vi antigen of Salmonella typhi. With Karber method, LD50 of challenging organism (S. typhi ty2) was determined as 6.31 CFU/mouse, and then the organism was used for the study. With Probits method, ED50 of the vaccine was determined as 0.016 microg / 0.5 ml / mouse. The ELISA titer (0.5097+/-0.060...
متن کاملIndian Vi conjugate typhoid vaccine: misleading claims.
447 VOLUME 47__MAY 17, 2010 I refer to the article “Vi conjugate Typhoid Vaccine” written by Garg SP(1) on behalf of the manufacturer of Peda TyphTM in response to my previous article on the same subject(2). The author states that “this novel vaccine has been found to be safe and effective in inducing very high levels of immune response (>90%) in infants, young children and adults”, and goes fu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2021
ISSN: ['1474-547X', '0099-5355', '0140-6736']
DOI: https://doi.org/10.1016/s0140-6736(21)01340-4